ID   LG2-EBV
AC   CVCL_C5U9
SY   LG2EBV; LG-2-EBV
DR   Wikidata; Q116049683
RX   PubMed=2967757;
RX   PubMed=8566071;
RX   PubMed=12747754;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C5U8 ! LG2-MEL
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
RX   PubMed=2967757; DOI=10.1002/eji.1830180503;
RA   Degiovanni G., Lahaye T., Herin M., Hainaut P., Boon T.;
RT   "Antigenic heterogeneity of a human melanoma tumor detected by
RT   autologous CTL clones.";
RL   Eur. J. Immunol. 18:671-676(1988).
//
RX   PubMed=8566071; DOI=10.1002/eji.1830260135;
RA   Brichard V.G., Herman J., Van Pel A., Wildmann C., Gaugler B.,
RA   Wolfel T., Boon T., Lethe B.;
RT   "A tyrosinase nonapeptide presented by HLA-B44 is recognized on a
RT   human melanoma by autologous cytolytic T lymphocytes.";
RL   Eur. J. Immunol. 26:224-230(1996).
//
RX   PubMed=12747754;
RA   Vigneron N., Ooms A., Morel S., Degiovanni G., van den Eynde B.J.;
RT   "Identification of a new peptide recognized by autologous cytolytic T
RT   lymphocytes on a human melanoma.";
RL   Cancer Immun. 2:9-9(2002).
//